Penumbra receives FDA clearance for Lightning technology to treat deep vein thrombosis
October 21, 2026
Clearance is supported by BOLT-DVT findings on clot removal, safety and patient outcomes
Clearance is supported by BOLT-DVT findings on clot removal, safety and patient outcomes
Edwards Lifesciences (NYSE: EW) obtained FDA approval for its minimally invasive procedure to help repair a leaky tricuspid heart valve.
An AI model created by researchers at King’s can detect signs of faulty repair mechanisms in ovarian cancer cells, potentially leading to a low-cost, widely accessible diagnostic tool in the future.
Reducing damage to the nuclei of heart muscle cells improved heart function and extended survival in mice with a form of inherited heart disease, according to a new study led by Cornell researchers.
In a potential advance for wearable technology, researchers from Virginia Commonwealth University and Florida International University have developed a cold-spray technique that can reliably deposit sensors directly onto human skin and other flexible surfaces.
Infrared light is invisible to us. Yet under the right conditions, pulses of near-infrared light can give rise to a visible image in the eye—one that behaves in ways that defy intuition. ICTER scientists investigated what happens to that image when it is no longer perfectly focused.